Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review.
Graziella OrrùCiro ConversanoEleonora MalloggiFrancesca FrancesconiRebecca CiacchiniAngelo GemignaniPublished in: International journal of environmental research and public health (2020)
The Coronavirus Disease 2019 (COVID-19) outbreak has shocked the whole world with its unexpected rapid spread. The virus responsible for the disease, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), enters host cells by means of the envelope spike protein, which binds to angiotensin-converting enzyme 2 receptors. These receptors are highly expressed in heart, lungs, respiratory tract epithelium, endothelial cells and brain. Since an increasing body of significant evidence is highlighting a possible neuroinvasion related to SARS-CoV-2, a state of the art on the neurological complications is needed. To identify suitable publications, our systematic review was carried out by searching relevant studies on PubMed and Scopus databases. We included studies investigating neurologic manifestations of SARS-CoV-2 in patients over 18. According to the analyzed studies, the most frequent disorders affecting central nervous system (CNS) seem to be the following: olfactory and taste disorders, ischemic/hemorrhagic stroke, meningoencephalitis and encephalopathy, including acute necrotizing encephalopathy, a rare type of encephalopathy. As regards the peripheral nervous system (PNS), Guillain-Barré and Miller Fisher syndromes are the most frequent manifestations reported in the literature. Important clinical information on the neurological manifestations of SARS-CoV-2 would help clinicians raise awareness and simultaneously improve the prognosis of critically ill patients.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- systematic review
- respiratory tract
- cerebral ischemia
- angiotensin converting enzyme
- early onset
- endothelial cells
- case control
- end stage renal disease
- ejection fraction
- angiotensin ii
- induced apoptosis
- risk factors
- atrial fibrillation
- chronic kidney disease
- newly diagnosed
- heart failure
- palliative care
- liver failure
- cell cycle arrest
- randomized controlled trial
- meta analyses
- peritoneal dialysis
- signaling pathway
- intensive care unit
- machine learning
- prognostic factors
- small molecule
- ischemia reperfusion injury
- social media
- deep learning
- patient reported outcomes
- pi k akt